We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13B
AUM Growth
+$984M
Cap. Flow
+$180M
Cap. Flow %
1.38%
Top 10 Hldgs %
38.14%
Holding
1,449
New
52
Increased
710
Reduced
341
Closed
132

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$287M
2
DLR icon
Digital Realty Trust
DLR
+$150M
3
HR icon
Healthcare Realty
HR
+$110M
4
WELL icon
Welltower
WELL
+$106M
5
O icon
Realty Income
O
+$88.1M

Top Sells

Rank Stock Value
1
DRE
Duke Realty Corp.
DRE
+$310M
2
SPG icon
Simon Property Group
SPG
+$93.4M
3
FR icon
First Industrial Realty Trust
FR
+$90.7M
4
PSA icon
Public Storage
PSA
+$88.6M
5
DOC icon
Healthpeak Properties
DOC
+$58M

Sector Composition

Rank Sector Weight
1 Real Estate 57.53%
2 Technology 9.67%
3 Healthcare 4.73%
4 Financials 4.38%
5 Consumer Discretionary 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMGN
1151
DELISTED
Immunogen Inc
IMGN
$4K ﹤0.01%
888
+195
+28% +$1.06K
RETA
1152
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$4K ﹤0.01%
108
– –
BLU
1153
DELISTED
BELLUS Health Inc.
BLU
$4K ﹤0.01%
506
+108
+27% +$1.01K
PRVB
1154
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$4K ﹤0.01%
351
+245
+231% +$1.98K
INBX
1155
DELISTED
Inhibrx, Inc. Common Stock
INBX
$4K ﹤0.01%
175
+64
+58% +$1.88K
ADMA icon
1156
ADMA Biologics
ADMA
$2.04B
$3K ﹤0.01%
791
+205
+35% +$632
ALEC icon
1157
Alector
ALEC
$170M
$3K ﹤0.01%
277
– –
ALLK
1158
DELISTED
Allakos
ALLK
$3K ﹤0.01%
343
+185
+117% +$1.28K
ALLO icon
1159
Allogene Therapeutics
ALLO
$614M
$3K ﹤0.01%
535
– –
ANAB icon
1160
AnaptysBio
ANAB
$1.54B
$3K ﹤0.01%
105
– –
ANIP icon
1161
ANI Pharmaceuticals
ANIP
$1.85B
$3K ﹤0.01%
+70
New +$2.63K
AVXL icon
1162
Anavex Life Sciences
AVXL
$232M
$3K ﹤0.01%
314
+92
+41% +$983
BCYC
1163
Bicycle Therapeutics
BCYC
$269M
$3K ﹤0.01%
103
+45
+78% +$1.21K
COGT icon
1164
Cogent Biosciences
COGT
$6.77B
$3K ﹤0.01%
281
+165
+142% +$2.04K
COLL icon
1165
Collegium Pharmaceutical
COLL
$1.18B
$3K ﹤0.01%
127
– –
ENTA icon
1166
Enanta Pharmaceuticals
ENTA
$364M
$3K ﹤0.01%
69
– –
FDMT icon
1167
4D Molecular Therapeutics
FDMT
$499M
$3K ﹤0.01%
130
+36
+38% +$556
FSLY icon
1168
CALL
Fastly Inc
FSLY
$3.19B
$3K ﹤0.01%
100
– –
GERN icon
1169
Geron
GERN
$924M
$3K ﹤0.01%
1,407
– –
GRFS
1170
Grifois
GRFS
$5.59B
$3K ﹤0.01%
398
– –
HCM icon
1171
HUTCHMED
HCM
$1.97B
$3K ﹤0.01%
185
– –
INVA icon
1172
Innoviva
INVA
$1.59B
$3K ﹤0.01%
260
– –
KURA icon
1173
Kura Oncology
KURA
$800M
$3K ﹤0.01%
227
– –
LYEL icon
1174
Lyell Immunopharma
LYEL
$321M
$3K ﹤0.01%
46
– –
MCRB icon
1175
Seres Therapeutics
MCRB
$45.8M
$3K ﹤0.01%
25
+9
+56% +$1.21K
45 46
47
48 49

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q4 2022 Portfolio in Review

As of Q4 2022, Daiwa Securities Group held 1,449 positions worth $13B, up 8.2% from $12B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q4 2022 filing shows 52 new, 710 increased, 341 reduced and 132 closed positions. Its largest new stake was Atlassian: 9,371 shares worth $1.21M. The largest sale was Duke Realty Corp., an estimated $310M.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q4 2022 buy was Atlassian: 9,371 shares worth $1.21M.
  • Daiwa Securities Group added most to Prologis in Q4 2022, an estimated $287M increase.
  • Daiwa Securities Group's biggest Q4 2022 reduction was Simon Property Group, cutting an estimated $93.4M.
  • Daiwa Securities Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $310M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13B portfolio in Q4 2022.
  • Daiwa Securities Group opened 52 new positions and closed 132 in Q4 2022.
  • Daiwa Securities Group's portfolio value rose 8.2% quarter-over-quarter to $13B.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.